# Pfizer Inc. (PFE) — Q3-2021 Earnings Results

**Report date:** 2021-11-02 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/PFE/earnings/Q3-2021

## Post-Earnings Brief

### Headline

Pfizer Beats on EPS, Stock Up 4.15%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.42 | N/A | +31.24% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed satisfaction with the EPS results, highlighting their commitment to ongoing projects. However, they did not provide specific guidance for future quarters.

**Key quotes:**

> We are pleased with our EPS performance this quarter.

> Our focus remains on delivering value through our ongoing projects.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Pfizer's strong EPS performance of $1.42, significantly above expectations, led to a positive stock reaction, with shares rising 4.15%. The company did not disclose revenue figures or future guidance, which leaves some uncertainty. Overall, the earnings report reflects Pfizer's solid performance in a competitive environment.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/PFE/earnings/Q3-2021_